Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years

World Journal of Urology

Volumn 37, Issue 7, 2019, Pages 1353-1360

  Sievert, Karl Dietrich ^a,b,c,h   Schonthaler, Martin ^d   Berges, Richard ^e   Toomey, Patricia ^a   Drager, Desiree ^c   Herlemann, Annika ^g   Miller, Florian ^a   Wetterauer, Ulrich ^d   Volkmer, Bjorn ^f   Gratzke, Christian ^g   Amend, Bastian ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e PAN Klinik am Neumarkt   (Germany)

^f KLINIKUM KASSEL   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

Benign prostatic hyperplasia (BPH); LUTS; Minimally invasive surgical therapy; Prostatic urethral lift (PUL); Transurethral resection of prostate

Indexed keywords

ADULT; AGED; CLINICAL TRIAL; COMPLICATION; GERMANY; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; MALE GENITAL SYSTEM SURGERY; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; MULTICENTER STUDY; PROSTATE HYPERTROPHY; PROSTHESIS IMPLANTATION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TRANSURETHRAL RESECTION; URETHRA OBSTRUCTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; GERMANY; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; PROSTATIC HYPERPLASIA; PROSTHESIS IMPLANTATION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TRANSURETHRAL RESECTION OF PROSTATE; URETHRAL OBSTRUCTION; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 85054483316     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-018-2494-1     Document Type: Article

References (29)

1. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE Jr, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT (2010) American urological association guideline: management of benign prostatic hyperplasia (BPH). J Urol 185(5):1793–1803. 10.1016/j.juro.2011.01.074
2. Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KAO, Gravas S (2016) EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), including benign prostatic obstruction (BPO). Eur J Urol 67(6):1099–1109. 10.1016/j.eururo.2014.12.038
3. Silva J, Silva CM, Cruz F (2014) Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard? Curr Opin Urol 24(1):21–28
4. Oelke M et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118–140
5. Verhamme KM et al (2003) Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol 44(5):539–545
6. Roehrborn CG (2008) Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. Rev Urol 10(1):14–25
7. Thomas JA, Tubaro A, Barber N et al (2016) A multicenter randomized noninferiority trial comparing GreenLght-XPS laser vaporiation of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 2 years outcomes of the COLIATH study. Eur J Urol 69(1):94–102
8. Rassweiler J et al (2006) Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50(5):969–980
9. Cornu JN, Ayhai S, Bathmann A et al (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur J Urol 67(6):1066–1096
10. Magistro G, Stief C, Gratzke C (2015) New intraprostatic injectables and prostate urethral lift for male LUTS. Nat Rev Urol 12(8):461–471
11. Yu X et al (2008) Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 180(1):241–245
12. Füllhase C, Hakenberg O (2015) New concepts for the treatment of male lower urinary tract symptoms. Curr Opin Urol 25(1):19–26
13. Schauer I, Madersbacher S (2014) Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015. Curr Opin Urol 5(1):6–11
14. Barkin J et al (2012) UroLift system for relief of prostate obstruction under local anesthesia. Can J Urol 19(2):6217–6222
15. McNicholas TA et al (2013) Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol 64(2):292–299
16. Marlon P et al (2015) Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol 67:704–713 (Addendum Eur Eurol 2015 68:E53–E54)
17. Roehrborn CG et al (2017) Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol 2017 24(3):8802–8813
18. Sievert KD, Kunit T (2017) Emerging techniques in ‘truly’ minimal-invasive treatment options of bening prostatic obstruction. Curr Opin Urol 27(3):287–292
19. Gratzke C et al (2017) Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int 119(5):767–775
20. Woo HH et al (2011) Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 108(1):82–88
21. Chin PT et al (2012) Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 79(1):5–11
22. Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Herron S, Rashid P, Rukstalis DB et al (2013) The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol 190(6):2161–2167
23. Shore N et al (2014) Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol 21(1):7094–7101
24. Sonkson J, Barber NJ, Speakman MJ (2015) Prospective, randomized multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12 months results from the BPH6 study. Eur J Urol 68(4):643–652
25. Kranse R, van Mastrigt R (2003) Weak correlation between bladder outlet obstruction and probability to void to completion. Urology 62:667–671
26. Bruskewitz RC, Iversen P, Madsen PO (1982) Value of postvoid residual urine determination in evaluation of prostatism. Urology 20(6):602–604
27. Roehrborn CG et al (2016) Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin N Am 53:357–369
28. McVary KT et al (2014) Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med 11(1):279–287
29. Berges R, Oelke M (2011) Age stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years and older. World J Urol 29:171–178